Stay updated on Efgartigimod in Post-COVID-19 POTS Clinical Trial
Sign up to get notified when there's something new on the Efgartigimod in Post-COVID-19 POTS Clinical Trial page.

Latest updates to the Efgartigimod in Post-COVID-19 POTS Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous v3.6.5. This indicates a small software/content update to the page.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page's revision indicator was updated to v3.6.5, replacing the previous v3.6.4, indicating a small release/maintenance update.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3. This indicates a backend or tooling update rather than a change to the visible study details.SummaryDifference0.0%

- Check58 days agoChange DetectedThe Publications section, including the PubMed-listed article and the auto-fill note about PubMed entries, has been removed from the study page. This reduces visible references and attribution for the study without altering core trial details.SummaryDifference0.2%

- Check72 days agoChange DetectedThe page's revision tag changed from v3.6.2 to v3.6.3, indicating an updated version of the page. This update does not modify the core study details or user-facing content beyond the version label.SummaryDifference0.0%

- Check80 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2, representing a newer version of the page's template or metadata. No substantive study details, eligibility criteria, or results appear to be changed.SummaryDifference0.0%

Stay in the know with updates to Efgartigimod in Post-COVID-19 POTS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efgartigimod in Post-COVID-19 POTS Clinical Trial page.